[{"Assets_0_Q3_USD":"4580697000.0","CIK":"1048477","CommonStockSharesConverted_0_Q3_shares":"175495350.0","CommonStockSharesOutstanding_0_Q3_shares":"175495350.0","Country":"United States","EarningsPerShareBasic_1_Q3_USD":"-0.07","EarningsPerShareBasic_3_Q3_USD":"-0.38","EarningsPerShareDiluted_1_Q3_USD":"-0.07","EarningsPerShareDiluted_3_Q3_USD":"-0.38","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","Market Cap":"14899091235.0","NetCashProvidedByUsedInOperatingActivitiesConverted_3_Q3_USD":"-23371000.0","NetIncomeLossAvailableToCommonStockholdersBasic_1_Q3_USD":"-12527000.0","NetIncomeLossAvailableToCommonStockholdersBasic_3_Q3_USD":"-65650000.0","NetIncomeLoss_1_Q3_USD":"-12527000.0","NetIncomeLoss_3_Q3_USD":"-65650000.0","OfficialName":"BioMarin Pharmaceutical Inc. Common Stock","RevenuesConverted_1_Q3_USD":"334148000.0","RevenuesConverted_3_Q3_USD":"955341000.0","SP500":null,"Sector":"Health Care","StockholdersEquity_0_Q3_USD":"2813562000.0","Ticker":"BMRN","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":"175103000.0","WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":"174071000.0","WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":"175103000.0","WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":"174071000.0","filed":"20171031","footnote":null,"form":"10-Q","fp":"Q3","fy":"2017.0","name":"BIOMARIN PHARMACEUTICAL INC","period":"20170930","qtrs":"0","uom":"USD"}]